- AstraZeneca (AZN) may be interested in buying Actelion (ALIOF), Citi says, in a note that sent shares of the Swiss biotech surging in overseas trade.
- Here's the actual quote (via Reuters): "Creative corporate finance
... coupled with 'long runway' acquisitions such as Actelion could provide a useful bridge to organically fueled growth."
- Citi thinks the deal would boost operating profits by double-digits for AZN.
at Zacks.com (Nov 18, 2014)